You have 9 free searches left this month | for more free features.

CF101

Showing 1 - 25 of 550

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Plaque Psoriasis Trial in Israel (CF101 1mg, CF101 2mg, CF101 4mg)

Completed
  • Plaque Psoriasis
  • CF101 1mg
  • +3 more
  • Afula, Israel
  • +3 more
Oct 13, 2020

COVID-19, Coronavirus Infection Trial in Bulgaria, Israel, Romania (Piclidenoson, Placebo)

Completed
  • COVID-19
  • Coronavirus Infection
  • Sofia, Bulgaria
  • +5 more
Apr 21, 2022

Plaque Psoriasis Trial in Worldwide (CF101, Placebo)

Completed
  • Plaque Psoriasis
  • CF101
  • Placebo
  • New York, New York
  • +17 more
Oct 31, 2020

Rheumatoid Arthritis Trial in Worldwide (CF101 1 mg, CF101 2 mg, Placebo)

Terminated
  • Rheumatoid Arthritis
  • CF101 1 mg
  • +3 more
  • Banja Luka, Bosnia and Herzegovina
  • +34 more
Dec 17, 2020

Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) Trial in Poland, United States (MS1819, Porcine PERT)

Completed
  • Exocrine Pancreatic Insufficiency (EPI)
  • Cystic Fibrosis (CF)
  • Long Beach, California
  • +14 more
Dec 17, 2021

Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)

Active, not recruiting
  • Advanced Follicular Lymphoma
  • Boulder, Colorado
  • +33 more
Nov 21, 2022

Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)

Suspended
  • Metastatic Breast Cancer
  • metastatic lesion biopsy
  • Brussels, Belgium
  • +59 more
Jan 17, 2023

Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

Recruiting
  • Tuberous Sclerosis Complex
  • Basimglurant with crossover to Placebo
  • Placebo with crossover to Basimglurant
  • Phoenix, Arizona
  • +47 more
Jan 3, 2023

HER2-ve Metastatic Breast Cancer, Germline BRCA1/2 Mutations, Somatic BRCA1/2 Mutations Trial in Worldwide (Olaparib)

Completed
  • HER2-ve Metastatic Breast Cancer
  • +2 more
  • Towson, Maryland
  • +122 more
Dec 22, 2022

Body Weight, Body Fat, Overweight Trial (Vigiis 101 Lactobacillus Capsules, Placebo Capsules)

Not yet recruiting
  • Body Weight
  • +2 more
  • Vigiis 101 Lactobacillus Capsules
  • Placebo Capsules
  • (no location specified)
May 18, 2023

Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

Not yet recruiting
  • Solid Tumor, Adult
  • CF33-CD19 IT
  • +2 more
  • (no location specified)
Sep 26, 2023

Healthy Trial in Davis (CF Control, CF-Theobromine, CF-Caffeine)

Completed
  • Healthy
  • CF Control
  • +2 more
  • Davis, California
  • +1 more
Oct 6, 2022

Primary Hyperoxaluria Trial in Worldwide (DCR-PHXC, Placebo)

Completed
  • Primary Hyperoxaluria
  • Boston, Massachusetts
  • +6 more
Jan 17, 2020

Cystic Fibrosis Trial in Worldwide (inhaled mannitol, Placebo comparator)

Completed
  • Cystic Fibrosis
  • inhaled mannitol
  • Placebo comparator
  • Tucson, Arizona
  • +52 more
Oct 6, 2020

Hepatocellular Carcinoma Trial in Worldwide (CF102, Placebo)

Completed
  • Hepatocellular Carcinoma
  • Aurora, Colorado
  • +20 more
Mar 7, 2022

Early Breast Cancer Trial in Worldwide (drug, procedure, radiation)

Active, not recruiting
  • Early Breast Cancer
  • Rockville, Maryland
  • +106 more
Jan 19, 2023

Cystic Fibrosis Lung Trial in United States (4D-710)

Recruiting
  • Cystic Fibrosis Lung
  • 4D-710
  • Denver, Colorado
  • +5 more
Jul 14, 2022

Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab

Recruiting
  • Leukemia, Acute Lymphoblastic
  • Omitted Doxorubicin
  • +5 more
  • Brussels, Belgium
  • +100 more
Dec 12, 2022

Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis Pulmonary Exacerbation
  • Sodium Fusidate
  • Placebo
  • (no location specified)
Dec 14, 2022

Squamous Cell Carcinoma (SCC), Recurrent or Metastatic, Platinum-refractory Cervical Cancer Trial in Worldwide (Cemiplimab,

Active, not recruiting
  • Squamous Cell Carcinoma (SCC)
  • Recurrent or Metastatic, Platinum-refractory Cervical Cancer
  • Phoenix, Arizona
  • +104 more
Mar 11, 2022

Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)

Active, not recruiting
  • Chronic Graft-versus-host Disease
  • Tucson, Arizona
  • +132 more
Oct 17, 2022

Cystic Fibrosis Reproductive and Sexual Health Collaborative:

Active, not recruiting
  • Cystic Fibrosis
  • Patient Engagement
  • 4-part educational program to build patient-engagement methodology capacity
  • Seattle, Washington
    University of Washington
Aug 13, 2021

Peanut Allergy Trial in Spain (AR101)

Terminated
  • Peanut Allergy
  • AR101
  • Badalona, Barcelona, Spain
  • +10 more
Jun 22, 2021

Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

Active, not recruiting
  • Urothelial Cancer
  • MEDI4736 (Durvalumab)
  • +4 more
  • Los Angeles, California
  • +221 more
Nov 2, 2022